Diagnosis (2): Disorders Causing Dementia and Cognitive Impairment

  • A. J. Larner


This chapter examines the various cognitive disorders (e.g. Alzheimer’s disease, frontotemporal lobar degenerations, parkinsonian disorders, cerebrovascular disorders) which may be defined by clinical assessment and investigation, emphasizing their clinical heterogeneity.


Dementia Diagnosis Cognitive disorders Alzheimer’s disease Frontotemporal lobar degeneration Parkinsonian disorders Vascular dementia 


  1. Abernethy Holland AJ, Larner AJ. Central nervous system/brain tumour 2-week referral guidelines: prospective 3-year audit. Clin Oncol. 2008;20:201–2.PubMedPubMedCentralCrossRefGoogle Scholar
  2. Adab N, Larner AJ. Adult-onset seizure disorder in 18q deletion syndrome. J Neurol. 2006;253:527–8.PubMedPubMedCentralCrossRefGoogle Scholar
  3. Aisen PS, Andrieu S, Sampaio C, et al. Report of the task force on designing clinical trials in early (predementia) AD. Neurology. 2011;76:280–6.PubMedCrossRefGoogle Scholar
  4. Aji BM, Medley G, O’Driscoll K, Larner AJ, Alusi SH. Perry syndrome: a disorder to consider in the differential diagnosis of parkinsonism. J Neurol Sci. 2013a;330:117–8.PubMedPubMedCentralCrossRefGoogle Scholar
  5. Aji BM, Fratalia L, Alusi SH, Larner AJ. Perry syndrome: more common than previously thought and associated with early cognitive impairment. Abstract Book. Integration by Translation. XX World Congress on Parkinson’s Disease and Related Disorders, Geneva, Switzerland, 8–11 December; 2013b. p. 106–7 (abstract 393).Google Scholar
  6. Ala T, Hughes LF, Kyrouac GA, Ghobrial MW, Elble RJ. The Mini-Mental State exam may help in the differentiation of dementia with Lewy bodies and Alzheimer’s disease. Int J Geriatr Psychiatry. 2002;17:503–9.PubMedCrossRefGoogle Scholar
  7. Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:270–9.PubMedPubMedCentralCrossRefGoogle Scholar
  8. Ali R, Barborie A, Larner AJ, White RP. Psychiatric presentation of sporadic Creutzfeldt-Jakob disease: a challenge to current diagnostic criteria. J Neuropsychiatry Clin Neurosci. 2013;25:335–8.PubMedPubMedCentralCrossRefGoogle Scholar
  9. Amato MP, Langdon D, Montalban X, et al. Treatment of cognitive impairment in multiple sclerosis: position paper. J Neurol. 2013;260:1452–68.PubMedCrossRefGoogle Scholar
  10. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed., text revison (DSM-IV-TR). Washington: American Psychiatric Association; 2000.Google Scholar
  11. Baborie A, Griffiths TD, Jaros E, Momeni P, McKeith IG, Burn DJ, Keir G, Larner AJ, Mann DM, Perry R. Frontotemporal dementia in elderly individuals. Arch Neurol. 2012;69:1052–60.PubMedCrossRefGoogle Scholar
  12. Baborie A, Griffiths TD, Jaros E, Momeni P, McKeith IG, Burn DJ, Keir G, Larner AJ, Mann DM, Perry R. Elderly individuals with FTLD. JAMA Neurol. 2013;70:412–3.PubMedCrossRefGoogle Scholar
  13. Ballard CG, Ayre G, O’Brien J, et al. Simple standardised neuropsychological assessments aid in the differential diagnosis of dementia with Lewy bodies from Alzheimer’s disease and vascular dementia. Dementia Geriatr Cogn Disord. 1999;10:104–8.CrossRefGoogle Scholar
  14. Boeve BF, Lang AE, Litvan I. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol. 2003;54(Suppl5):S15–9.PubMedCrossRefGoogle Scholar
  15. Boeve BF, Silber MH, Saper CB, et al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain. 2007;130:2770–88.PubMedPubMedCentralCrossRefGoogle Scholar
  16. Boeve BF, Bovlan KB, Graff-Radford NR, et al. Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain. 2012;135:765–83.PubMedPubMedCentralCrossRefGoogle Scholar
  17. Bowler JV, Hachinski V, editors. Vascular cognitive impairment: preventable dementia. Oxford: Oxford University Press; 2003.Google Scholar
  18. Burns JM, Morris JC. Mild cognitive impairment and early Alzheimer’s disease. Detection and diagnosis. Chichester: Wiley; 2008.Google Scholar
  19. Cairns NJ, Grossman M, Arnold SE, et al. Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease. Neurology. 2004;63:1376–84.PubMedPubMedCentralCrossRefGoogle Scholar
  20. Calderon J, Perry R, Erzinclioglu S, Berrios GE, Dening T, Hodges JR. Perception, attention and working memory are disproportionately impaired in dementia with Lewy bodies compared with Alzheimer’s disease (AD). J Neurol Neurosurg Psychiatry. 2001;70:157–64.Google Scholar
  21. Caselli RJ, Tariot PN. Alzheimer's disease and its variants: a diagnostic and therapeutic guide. Oxford: Oxford University Press; 2010.Google Scholar
  22. Clifford DB. HIV-associated neurocognitive disorder. Curr Opin Infect Dis. 2017;30:117–22.PubMedPubMedCentralGoogle Scholar
  23. Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci. 2001;24:519–50.PubMedCrossRefGoogle Scholar
  24. Connon P, Larner AJ. Fragile X-associated tremor/ataxia syndrome: cognitive presentations. Br J Hosp Med. 2017;78:230–1.CrossRefGoogle Scholar
  25. Cruts M, van Duijn CM, Backhovens H, et al. Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. Hum Mol Genet. 1998;7:43–51.PubMedPubMedCentralCrossRefGoogle Scholar
  26. Davies M, Larner AJ. Clinical misdiagnosis of Alzheimer’s disease: getting it wrong again. Eur J Neurol. 2009;16(Suppl3):351. (abstract 2036).Google Scholar
  27. Davies M, Larner AJ. Frontotemporal dementias: development of an integrated care pathway through an experiential survey of patients and carers. Int J Care Pathways. 2010;14:65–9.CrossRefGoogle Scholar
  28. Davies RR, Doran M, Larner AJ. Early-onset dementia. Prog Neurol Psychiatry. 2011;15(4):12–6.CrossRefGoogle Scholar
  29. De Mendonca A, Ribeiro F, Guerreiro M, Garcia C. Frontotemporal mild cognitive impairment. J Alzheimers Dis. 2004;6:1–9.PubMedCrossRefGoogle Scholar
  30. De Simone R, Puig XS, Gélisse P, Crespel A, Genton P. Senile myoclonic epilepsy: delineation of a common condition associated with Alzheimer’s disease in Down syndrome. Seizure. 2010;19:383–9.PubMedCrossRefGoogle Scholar
  31. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, et al. Expanded GGGGCC hexanucelotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245–56.PubMedPubMedCentralCrossRefGoogle Scholar
  32. Dickerson BC, editor. Hodges’ frontotemporal dementia. 2nd ed. Cambridge: Cambridge University Press; 2016.Google Scholar
  33. Dickerson B, Atri A, editors. Dementia. Comprehensive principles and practice. Oxford: Oxford University Press; 2014.Google Scholar
  34. Dobson-Stone C, Hallupp M, Bartley L, et al. C9ORF72 repeat expansion in clinical and neuropathologic frontotemporal dementia cohorts. Neurology. 2012;79:995–1001.PubMedPubMedCentralCrossRefGoogle Scholar
  35. Doran M. Diagnosis of presenile dementia. Br J Hosp Med. 1997;58:105–10.PubMedPubMedCentralGoogle Scholar
  36. Doran M, Larner AJ. Prominent behavioural and psychiatric symptoms in early-onset Alzheimer’s disease in a sib pair with the presenilin-1 gene R269G mutation. Eur Arch Psychiatry Clin Neurosci. 2004a;254:187–9.PubMedPubMedCentralCrossRefGoogle Scholar
  37. Doran M, Larner AJ. EEG findings in dementia with Lewy bodies causing diagnostic confusion with sporadic Creutzfeldt-Jakob disease. Eur J Neurol. 2004b;11:838–41.PubMedPubMedCentralCrossRefGoogle Scholar
  38. Doran M, Larner AJ. Familial Alzheimer’s disease due to presenilin-1 Y115C mutation. J Neurol. 2006;253(Suppl 2):II91. (Poster P359).Google Scholar
  39. Doran M, Larner AJ. Monogenic Mendelian causes of dementia: ten-year survey of a dementia clinic. Eur J Neurol. 2009;16(Suppl3):291. (abstract P1731).Google Scholar
  40. Doran M, du Plessis DG, Enevoldson TP, Fletcher NA, Ghadiali E, Larner AJ. Pathological heterogeneity of clinically diagnosed corticobasal degeneration. J Neurol Sci. 2003;216:127–34.PubMedPubMedCentralCrossRefGoogle Scholar
  41. Doran M, Enevoldson TP, Ghadiali EJ, Larner AJ. Mills syndrome with dementia: broadening the phenotype of FTD/MND. J Neurol. 2005;252:846–7.PubMedPubMedCentralCrossRefGoogle Scholar
  42. Downes JJ, Priestley NM, Doran M, Ferran J, Ghadiali E, Cooper P. Intellectual, mnemonic and frontal functions in dementia with Lewy bodies: a comparison with early and advanced Parkinson’s disease. Behav Neurol. 1998;11:173–83.PubMedCrossRefGoogle Scholar
  43. Du Plessis DG, Larner AJ. Phenotypic similarities causing clinical misdiagnosis of pathologically-confirmed sporadic Creutzfeldt-Jakob disease as dementia with Lewy bodies. Clin Neurol Neurosurg. 2008;110:194–7.PubMedPubMedCentralCrossRefGoogle Scholar
  44. Dubois B, Feldman HH, Jacova C, et al. Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007;6:734–46.PubMedPubMedCentralCrossRefGoogle Scholar
  45. Dubois B, Feldman HH, Jacova C, et al. Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. Lancet Neurol. 2014;13:614–29. [Erratum Lancet Neurol. 2014;13:757].PubMedPubMedCentralCrossRefGoogle Scholar
  46. el Tawil S, Mackay G, Davidson L, Summers D, Knight R. Will R. Variant Creutzfeldt-Jakob disease in older patients. J Neurol Neurosurg Psychiatry. 2015;86:1279–80.PubMedPubMedCentralCrossRefGoogle Scholar
  47. Ellis RJ, Mbizvo GK, Jacob A, Doran M, Larner AJ. Relapsing polychondritis complicated by cognitive dysfunction: two distinct clinical phenotypes? Int J Neurosci. 2017;127:124–34.PubMedPubMedCentralCrossRefGoogle Scholar
  48. Filley CM. The behavioral neurology of white matter. 2nd ed. Oxford: Oxford University Press; 2012.CrossRefGoogle Scholar
  49. Gaig C, Valledeoriola F, Gelpi E, et al. Rapidly progressive diffuse Lewy body disease. Mov Disord. 2011;26:1316–23.PubMedCrossRefGoogle Scholar
  50. Geschwind MD, Tan KM, Lennon VA, et al. Voltage-gated potassium channel autoimmunity mimicking Creutzfeldt-Jakob disease. Arch Neurol. 2008;65:1341–6.PubMedPubMedCentralCrossRefGoogle Scholar
  51. Ghadiri-Sani M, Sekhar A, Larner AJ. A stroke of ill-fortune: an unexpected diagnosis following a stroke-like event. Br J Hosp Med. 2015;76:54–5.CrossRefGoogle Scholar
  52. Gill ON, Spencer Y, Richard-Loendt A, et al. Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey. BMJ. 2013;347:f5675.PubMedPubMedCentralCrossRefGoogle Scholar
  53. Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:2672–713.PubMedPubMedCentralCrossRefGoogle Scholar
  54. Gorno-Tempini ML, Hillis AE, Weintraub S, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76:1006–14.PubMedPubMedCentralCrossRefGoogle Scholar
  55. Haïk S, Brandel J-P, Sazdovitch V, et al. Dementia with Lewy bodies in a neuropathologic series of suspected Creutzfeldt-Jakob disease. Neurology. 2000;55:1401–4.PubMedCrossRefGoogle Scholar
  56. Hancock P, Larner AJ. A case of frontotemporal lobar degeneration with MND. Prog Neurol Psychiatry. 2008;12(3):15–8.Google Scholar
  57. Harvey RJ, Skelton-Robinson M, Rossor MN. The prevalence and causes of dementia in people under the age of 65 years. J Neurol Neurosurg Psychiatry. 2003;74:1206–9.CrossRefGoogle Scholar
  58. Hodges JR, editor. Frontotemporal dementia syndromes. Cambridge: Cambridge University Press; 2007.Google Scholar
  59. Hsiung GY, DeJesus-Hernandez M, Feldman HH, et al. Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p. Brain. 2012;135:709–22.PubMedPubMedCentralCrossRefGoogle Scholar
  60. Jayaratnam S, Khoo AK, Basic D. Rapidly progressive Alzheimer’s disease and elevated 14-3-3 proteins in cerebrospinal fluid. Age Ageing. 2008;37:467–9.PubMedPubMedCentralCrossRefGoogle Scholar
  61. Kozora E, Filley CM. Cognitive dysfunction and white matter abnormalities in systemic lupus erythematosus. J Int Neuropsychol Soc. 2011;17:385–92.PubMedCrossRefGoogle Scholar
  62. Kurlan R, editor. Handbook of secondary dementias. New York: Taylor and Francis; 2006.Google Scholar
  63. Langa KM, Foster NL, Larson EB. Mixed dementia: emerging concepts and therapeutic implications. JAMA. 2004;292:2901–8.PubMedCrossRefGoogle Scholar
  64. Larner AJ. Adult-onset dementia with prominent frontal lobe dysfunction in X-linked adrenoleukodystrophy with R152C mutation in ABCD1 gene. J Neurol. 2003;250:1253–4.PubMedPubMedCentralCrossRefGoogle Scholar
  65. Larner AJ. Getting it wrong: the clinical misdiagnosis of Alzheimer’s disease. Int J Clin Pract. 2004;58:1092–4.PubMedPubMedCentralCrossRefGoogle Scholar
  66. Larner AJ. Frequency of agnosic, apraxic and aphasic presentations of Alzheimer’s disease. Eur J Neurol. 2006a;13(Suppl 2):193. (abstract P2098).Google Scholar
  67. Larner AJ. Creutzfeldt-Jakob disease misdiagnosed as dementia with Lewy bodies: response to the paper by Kraemer et al. (J Neurol 2005;252:861-2). J Neurol. 2006b;253:960.PubMedCrossRefGoogle Scholar
  68. Larner AJ. Down syndrome in the neurology clinic: Too much? Too little? Too late? Down Syndr Res Pract. 2007;12:69–71.CrossRefGoogle Scholar
  69. Larner AJ. Neuropsychological neurology: the neurocognitive impairments of neurological disorders. Cambridge: Cambridge University Press; 2008a.CrossRefGoogle Scholar
  70. Larner AJ. Alzheimer’s disease. In: Cappa SF, Abutalebi J, Démonet JF, Fletcher PC, Garrard P, editors. Cognitive neurology: a clinical textbook. Oxford: Oxford University Press; 2008b. p. 199–227.CrossRefGoogle Scholar
  71. Larner AJ. Mutation negative early-onset familial Alzheimer disease: consider screening for tau gene mutations. Alzheimer Dis Assoc Disord. 2008c;22:194–5.PubMedPubMedCentralCrossRefGoogle Scholar
  72. Larner AJ. Delusion of pregnancy in frontotemporal lobar degeneration with motor neurone disease (FTLD/MND). Behav Neurol. 2008d;19:199–200.PubMedPubMedCentralCrossRefGoogle Scholar
  73. Larner AJ. Monogenic Mendelian disorders in general neurological practice. Int J Clin Pract. 2008e;62:744–6.PubMedPubMedCentralCrossRefGoogle Scholar
  74. Larner AJ. A 50-year old man with deteriorating cognitive function and impaired movement. PLoS Med. 2009a;6(1):e1000019.CrossRefGoogle Scholar
  75. Larner AJ. Deletion of 18q. In: Lang F, editor. Encyclopedia of molecular mechanisms of disease (3 volumes). Berlin: Springer; 2009b. p. 503–4.Google Scholar
  76. Larner AJ. What’s new in dementia? Clin Med. 2010a;10:391–4.CrossRefGoogle Scholar
  77. Larner AJ. Neurological signs: lycanthropy. Adv Clin Neurosci Rehabil. 2010b;10(4):50.Google Scholar
  78. Larner AJ. Cholinesterase inhibitors—beyond Alzheimer’s disease. Exp Rev Neurotherapeutics. 2010c;10:1699–705.CrossRefGoogle Scholar
  79. Larner AJ. Senile myoclonic epilepsy in Down syndrome. Seizure. 2011a;20:512.PubMedPubMedCentralCrossRefGoogle Scholar
  80. Larner AJ. Presenilin 1 mutation Alzheimer’s disease: a genetic epilepsy syndrome? Epilepsy Behav. 2011b;21:20–2.PubMedPubMedCentralCrossRefGoogle Scholar
  81. Larner AJ. Progressive nonfluent aphasia in a bilingual subject: relative preservation of mother tongue. J Neuropsychiatry Clin Neurosci. 2012a;24:E9–10.PubMedCrossRefGoogle Scholar
  82. Larner AJ. Intrafamilial clinical phenotypic heterogeneity with progranulin gene p.Glu498fs mutation. J Neurol Sci. 2012b;316:189–90.PubMedPubMedCentralCrossRefGoogle Scholar
  83. Larner AJ. FTDP-17: two-year follow-up of motor and cognitive features following autologous stem cell transplantation. J Neuropsychiatry Clin Neurosci. 2012c;24:E1–2.Google Scholar
  84. Larner AJ. Neuropsychological neurology: the neurocognitive impairments of neurological disorders. 2nd ed. Cambridge: Cambridge University Press; 2013a.CrossRefGoogle Scholar
  85. Larner AJ. Delusion of pregnancy: a case revisited. Behav Neurol. 2013b;27:293–4.PubMedPubMedCentralCrossRefGoogle Scholar
  86. Larner AJ. Presenilin-1 mutations in Alzheimer’s disease: an update on genotype-phenotype relationships. J Alzheimers Dis. 2013c;37:653–9.PubMedPubMedCentralCrossRefGoogle Scholar
  87. Larner AJ. Cerebral mass lesions presenting in a cognitive disorders clinic. Br J Hosp Med. 2013d;74:694–5.CrossRefGoogle Scholar
  88. Larner AJ. Neurological update: dementia. J Neurol. 2014;261:635–9.PubMedCrossRefGoogle Scholar
  89. Larner AJ. FRONTIER Executive Screen (FES). Poster P0034, Association of British Neurologists Annual Meeting, Liverpool, 3–5 May, 2017.Google Scholar
  90. Larner AJ, Doran M. Prion disease at a regional neuroscience centre: retrospective audit. J Neurol Neurosurg Psychiatry. 2004;75:1789–90.PubMedPubMedCentralCrossRefGoogle Scholar
  91. Larner AJ, Doran M. Clinical phenotypic heterogeneity of Alzheimer’s disease associated with mutations of the presenilin-1 gene. J Neurol. 2006;253:139–58.PubMedPubMedCentralCrossRefGoogle Scholar
  92. Larner AJ, Doran M. Clinical heterogeneity associated with tau gene mutations. Eur Neurol Rev. 2009a;3(2):31–2.CrossRefGoogle Scholar
  93. Larner AJ, Doran M. Genotype-phenotype relationships of presenilin-1 mutations in Alzheimer’s disease: an update. J Alzheimers Dis. 2009b;17:259–65.PubMedPubMedCentralCrossRefGoogle Scholar
  94. Larner AJ, du Plessis DG. Early-onset Alzheimer’s disease with presenilin-1 M139V mutation: clinical, neuropsychological and neuropathological study. Eur J Neurol. 2003;10:319–23.PubMedPubMedCentralCrossRefGoogle Scholar
  95. Larner AJ, Gardner-Thorpe C. Mills syndrome with dementia. Eur Neurol J. 2012;4(2):29–32.Google Scholar
  96. Larner AJ, Mathias CJ, Rossor MN. Autonomic failure preceding dementia with Lewy bodies. J Neurol. 2000;247:229–31.PubMedCrossRefGoogle Scholar
  97. Larner AJ, Brookfield K, Flynn A, Ghadiali EJ, Smith ETS, Doran M. The cerebral metabolic topography of semantic dementia. J Neurol. 2005a;252(Suppl 2):II106. (abstract P399).Google Scholar
  98. Larner AJ, Hart IK, Cresswell P, Doran M. REM sleep behaviour disorder in the cognitive function clinic. Eur J Neurol. 2005b;12(Suppl2):218. (abstract 2211).Google Scholar
  99. Larner AJ, Ray PS, Doran M. The R269H mutation in presenilin-1 presenting as late-onset autosomal dominant Alzheimer’s disease. J Neurol Sci. 2007;252:173–6.PubMedPubMedCentralCrossRefGoogle Scholar
  100. Le Ber I, Camuzat A, Guillot-Noel L, et al. C9ORF72 repeat expansions in the frontotemporal dementias spectrum of diseases: a flow-chart for genetic testing. J Alzheimers Dis. 2013;34:485–99.Google Scholar
  101. Lindquist SG, Holm IE, Schwartz M, et al. Alzheimer disease-like clinical phenotype in a family with FTDP-17 caused by a MAPT R406W mutation. Eur J Neurol. 2008;15:377–85.PubMedCrossRefGoogle Scholar
  102. Litvan I, Goldman JG, Troster AI, et al. Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Mov Disord. 2012;27:349–56.PubMedPubMedCentralCrossRefGoogle Scholar
  103. Lorains JW, Henry C, Agbamu DA, Rossi M, Bishop M, Will RG, Ironside JW. Variant Creutzfeldt-Jakob disease in an elderly patient. Lancet. 2001;357:1339–40.PubMedCrossRefGoogle Scholar
  104. Mackenzie IR, Neumann M, Bigio EH, et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol. 2010;119:1–4.PubMedCrossRefGoogle Scholar
  105. Mahoney CJ, Beck J, Rohrer JD, et al. Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain. 2012;135:736–50.PubMedPubMedCentralCrossRefGoogle Scholar
  106. Majounie E, Renton AE, Mok K, et al. Frequency of the C9orf72 hexanucelotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol. 2012;11:323–30.PubMedPubMedCentralCrossRefGoogle Scholar
  107. McCormick LJ, Larner AJ. “Could you repeat that?”: not always a hearing problem! Br J Hosp Med. 2018;79. (in press)Google Scholar
  108. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology. 2005;65:1863–72.PubMedPubMedCentralCrossRefGoogle Scholar
  109. McKeith IG, Boeve BF, Dickson DW, et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB consortium. Neurology. 2017;89:88–100.PubMedPubMedCentralCrossRefGoogle Scholar
  110. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer’s disease. Report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Service Task forces on Alzheimer’s disease. Neurology. 1984;34:939–44.PubMedPubMedCentralCrossRefGoogle Scholar
  111. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:263–9.PubMedPubMedCentralCrossRefGoogle Scholar
  112. Mendez MF, Cummings JL. Dementia: a clinical approach. 3rd ed. Philadelphia: Butterworth-Heinemann; 2003.Google Scholar
  113. Menon R, Barborie A, Jaros E, Mann DMA, Ray PS, Larner AJ. What’s in a name? Neuronal intermediate filament inclusion disease (NIFID), frontotemporal lobar degeneration-intermediate filament (FTLD-IF) or frontotemporal lobar degeneration-fused in sarcoma (FTLD-FUS)? J Neurol Neurosurg Psychiatry. 2011;82:1412–4.PubMedPubMedCentralCrossRefGoogle Scholar
  114. Milburn-McNulty P, Larner AJ. Episodic loss of consciousness: when targeted genetic testing contributes to diagnosis. Prog Neurol Psychiatry. 2018;22. (in press)Google Scholar
  115. Mitchell AJ, Shiri-Feshki M. Rate of progression of mild cognitive impairment to dementia—meta-analysis of 41 robust inception cohort studies. Acta Psychiatr Scand. 2009;119:252–65.PubMedCrossRefGoogle Scholar
  116. Momjian-Mayor I, Pizzolato GP, Burkhardt K, et al. Fulminant Lewy body disease. Mov Disord. 2006;21:1748–51.PubMedCrossRefGoogle Scholar
  117. Mrak RE, Griffin WS. Trisomy 21 and the brain. J Neuropathol Exp Neurol. 2004;63:679–85.PubMedPubMedCentralCrossRefGoogle Scholar
  118. Nakatani E, Kanatani Y, Kaneda H, et al. Specific clinical signs and symptoms are predictive of clinical course in sporadic Creutzfeldt-Jakob disease. Eur J Neurol. 2016;23:1455–62.PubMedPubMedCentralCrossRefGoogle Scholar
  119. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51:1546–54.PubMedPubMedCentralCrossRefGoogle Scholar
  120. Neumann M, Roeber S, Kretzschmar HA, Rademakers R, Baker M, Mackenzie IRA. Abundant FUS pathology in neuronal intermediate filament inclusion disease. Acta Neuropathol. 2009;118:605–16.PubMedPubMedCentralCrossRefGoogle Scholar
  121. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study. Lancet. 2001;357:169–75.CrossRefGoogle Scholar
  122. Nicholas RS, Partridge J, Donn RP, Hawkins C, Boggild MD. The role of the PTPRC (CD45) mutation in the development of multiple sclerosis in the North West region of the United Kingdom. J Neurol Neurosurg Psychiatry. 2003;74:944–5.PubMedPubMedCentralCrossRefGoogle Scholar
  123. Petersen RC, editor. Mild cognitive impairment. Aging to Alzheimer’s disease. Oxford: Oxford University Press; 2003.Google Scholar
  124. Prasher VP. Alzheimer’s disease and dementia in Down syndrome and intellectual disabilities. Oxford: Radcliffe Publishing; 2005.Google Scholar
  125. Rabinovici GD, Wang PN, Levin CM, et al. First symptom in sporadic Creutzfeldt-Jakob disease. Neurology. 2006;66:286–7.PubMedCrossRefGoogle Scholar
  126. Randall A, Ellis R, Hywel B, Davies RR, Alusi SH, Larner AJ. Rapid cognitive decline: not always Creutzfeldt-Jakob disease. J R Coll Phys Edinb. 2015;45:209–12.CrossRefGoogle Scholar
  127. Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134:2456–77.PubMedPubMedCentralCrossRefGoogle Scholar
  128. Ratnavalli E, Brayne C, Dawson K, Hodges JR. The prevalence of frontotemporal dementia. Neurology. 2002;58:1615–21.PubMedCrossRefGoogle Scholar
  129. Reid WG, Hely MA, Morris JG, Loy C, Halliday GM. Dementia in Parkinson’s disease: a 20-year neuropsychological study (Sydney Multicentre Study). J Neurol Neurosurg Psychiatry. 2011;82:1033–7.PubMedCrossRefGoogle Scholar
  130. Renton AE, Majounie E, Waite A, et al. A hexanucelotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257–68.PubMedPubMedCentralCrossRefGoogle Scholar
  131. Rohrer JD, Guerriero R, Vandrovcova J, et al. The heritability and genetics of frontotemporal lobar degeneration. Neurology. 2009;73:1451–6.PubMedPubMedCentralCrossRefGoogle Scholar
  132. Román GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC. Subcortical ischaemic vascular dementia. Lancet Neurol. 2002;1:426–36.PubMedCrossRefGoogle Scholar
  133. Rosness TA, Haugen PK, Passant U, Engedal K. Frontotemporal dementia—a clinically complex diagnosis. Int J Geriatr Psychiatry. 2008;23:837–42.PubMedPubMedCentralCrossRefGoogle Scholar
  134. Rossor MN, Fox NC, Mummery CJ, Schott JM, Warren JD. The diagnosis of young-onset dementia. Lancet Neurol. 2010;9:793–806.PubMedPubMedCentralCrossRefGoogle Scholar
  135. Salmon DP, Galasko D, Hansen LA, et al. Neuropsychological deficits associated with diffuse Lewy body disease. Brain Cogn. 1996;31:148–65.PubMedCrossRefGoogle Scholar
  136. Sathasivam S, Doran M, Larner AJ. Frontotemporal lobar degeneration with motor neurone disease (FTLD/MND): presentations in psychiatric practice. Int J Psychiatry Clin Pract. 2008;12:138–41.PubMedPubMedCentralCrossRefGoogle Scholar
  137. Schmidt C, Redyk K, Meissner B, et al. Clinical features of rapidly progressive Alzheimer's disease. Dement Geriatr Cogn Disord. 2010;29:371–8.PubMedCrossRefGoogle Scholar
  138. Schneider JA, Aggarwal NT, Barnes L, Boyle P, Bennett DA. The neuropathology of older persons with and without dementia from community versus clinic cohorts. J Alzheimers Dis. 2009;18:691–701.PubMedPubMedCentralCrossRefGoogle Scholar
  139. Schott JM, Warren JD, Rossor MN. The uncertain nosology of Hashimoto encephalopathy. Arch Neurol. 2003;60:1812.PubMedCrossRefGoogle Scholar
  140. Schott JM, Williams DR, Butterworth RJ, Janssen JC, Larner AJ, Holton JL, Rossor MN. Shunt responsive progressive supranuclear palsy? Mov Disord. 2007;22:902–3.PubMedPubMedCentralCrossRefGoogle Scholar
  141. Seelaar H, Kamphorst W, Rosso SM, et al. Distinct genetic forms of frontotemporal dementia. Neurology. 2008;71:1220–6.PubMedCrossRefGoogle Scholar
  142. Sells RA, Larner AJ. Genetic causes of learning disability with epilepsy in the general neurology clinic. Eur J Neurol. 2011;18(Suppl2):184. (abstract P1315).Google Scholar
  143. Silverdale M, Leach JP, Chadwick DW. New variant Creutzfeldt-Jakob disease presenting as localization-related epilepsy. Neurology. 2000;54:2188.PubMedCrossRefGoogle Scholar
  144. Simon-Sanchez J, Dopper EG, Cohn-Hokke PE, et al. The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions. Brain. 2012;135:723–35.PubMedCrossRefGoogle Scholar
  145. Snowden JS, Neary D, Mann DMA. Fronto-temporal lobar degeneration. Fronto-temporal dementia, progressive aphasia, semantic dementia. New York: Churchill Livingstone; 1996.Google Scholar
  146. Snowden JS, Rollinson S, Thompson JC, et al. Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain. 2012;135:693–708.PubMedPubMedCentralCrossRefGoogle Scholar
  147. Snowdon DA, Greiner LH, Mortimer JA, et al. Brain infarction and the clinical expression of Alzheimer’s disease. The Nun Study. JAMA. 1997;277:813–7.PubMedCrossRefGoogle Scholar
  148. Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:280–92.PubMedPubMedCentralCrossRefGoogle Scholar
  149. Struwe F. Histopathologische Untersuchungen über entstehung und wesen der senile Plaques. Zeitschrift für die gesamte Neurologie und Psychiatrie. 1929;122:291–307.CrossRefGoogle Scholar
  150. Tschampa HJ, Neumann M, Zerr I, et al. Patients with Alzheimer’s disease and dementia with Lewy bodies mistaken for Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry. 2001;71:33–9.PubMedPubMedCentralCrossRefGoogle Scholar
  151. Van Everbroeck B, Dobbeleir I, De Waele M, De Deyn P, Martin J-J, Cras P. Differential diagnosis of 201 possible Creutzfeldt-Jakob disease patients. J Neurol. 2004;251:298–304.PubMedCrossRefGoogle Scholar
  152. Varma AR, Snowden JS, Lloyd JJ, et al. Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer’s disease and frontotemporal dementia. J Neurol Neurosurg Psychiatry. 1999;66:184–8.PubMedPubMedCentralCrossRefGoogle Scholar
  153. Wahlund L-O, Erkinjuntti T, Gauthier S, editors. Vascular cognitive impairment in clinical practice. Cambridge: Cambridge University Press; 2009.Google Scholar
  154. Walker Z, Possin KL, Boeve BF, Aarsland D. Lewy body dementias. Lancet. 2015;386:1683–97.PubMedPubMedCentralCrossRefGoogle Scholar
  155. Wall CA, Rummans TA, Aksamit AJ, Krah LE, Pankratz VS. Psychiatric manifestations of Creutzfeldt-Jakob disease: a 25-year analysis. J Neuropsychiatry Clin Neurosci. 2005;17:489–95.PubMedCrossRefGoogle Scholar
  156. Warren JD, Rohrer JD, Rossor MN. Clinical review. Frontotemporal dementia. BMJ. 2013;347:f4827.PubMedPubMedCentralCrossRefGoogle Scholar
  157. Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet. 1996;347:921–5.PubMedCrossRefGoogle Scholar
  158. Williams-Gray CH, Mason SL, Evans JR, et al. The CamPaIGN study of Parkinson’s disease: 10-year outlook in an incident population-based cohort. J Neurol Neurosurg Psychiatry. 2013;84:1258–64.PubMedCrossRefGoogle Scholar
  159. Williamson J, Larner AJ. Young-onset cognitive decline: not always variant Creutzfeldt-Jakob disease. Eur J Neurol. 2016;23(Suppl 1):368. (abstract P21049).Google Scholar
  160. Wilson M, Doran M, Enevoldson TP, Larner AJ. Cognitive profiles associated with intracranial dural arteriovenous fistula. Age Ageing. 2010;39:389–92.CrossRefPubMedPubMedCentralGoogle Scholar
  161. Young CA, Boggild M, Larner AJ. A familial syndrome of multiple sclerosis, early-onset dementia and epilepsy. Eur J Neurol. 2008;15(Suppl3):142. (abstract P1428).Google Scholar
  162. Zaccai J, McCracken C, Brayne C. A systematic study of prevalence and incidence studies of dementia with Lewy bodies. Age Ageing. 2005;34:561–6.Google Scholar
  163. Ziso B, Marsden D, Alusi S, Larner AJ. “Undifferentiated schizophrenia” revisited. J Neuropsychiatry Clin Neurosci. 2014;26:E62–3.PubMedPubMedCentralCrossRefGoogle Scholar
  164. Ziso B, Larner AJ, Alusi SH. Stuck in the middle: Huntington’s disease or not Huntington’s disease? J Neuropsychiatry Clin Neurosci. 2015;27:e85–6.PubMedPubMedCentralCrossRefGoogle Scholar
  165. Ziso B, Larner AJ, Aji BM. Suspected cervical myelopathy: an unexpected diagnosis. Br J Hosp Med. 2017;78:50–1.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • A. J. Larner
    • 1
  1. 1.Cognitive Function ClinicWalton Centre for Neurology and NeurosurgeryLiverpoolUK

Personalised recommendations